Medico Remedies cash flow

·Pharma & HealthChart ›
Latest FY26
Cash from operations
₹5.9cr+20.1% on FY25
Capital spending
₹0.0crNo figure a year before
Free cash flow
₹5.9cr+20.1% on FY25
Cash from financing
−₹0.6cr−₹0.5 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
Adjustments to reconcile profit — non-cash items
—3.13.02.92.7
—−0.10.00.00.0
—−0.00.00.00.0
—0.0−0.60.60.3
—0.00.10.10.5
—0.20.00.00.0
Changes in working capital
—−3.3−10.43.4−1.6
—0.0−7.0−13.6−5.7
—−25.10.00.00.0
—0.00.00.30.3
—−0.0−0.00.00.0
—−0.0−4.00.30.6
—−2.80.00.00.0
—14.63.20.53.9
—0.03.80.00.0
—1.87.1−0.0−0.2
—4.70.00.00.0
—−0.10.0−0.1−0.1
Cash from operating activities
19.018.113.511.310.1
—−7.1−4.7−5.60.6
—10.98.85.710.7
—0.0−0.1−0.1−0.1
—5.13.83.22.5
—5.94.92.48.2
Cash from investing activities
—0.10.00.00.0
—0.40.10.10.1
—0.00.00.00.0
—0.10.10.10.1
—−4.3−3.5−2.7−6.6
—−4.5−3.5−2.7−6.6
Cash from financing activities
—0.00.00.01.3
—0.60.50.50.5
—0.00.00.00.1
—−0.6−0.5−0.5−1.8
—0.80.9−0.7−0.3
—0.80.9−0.7−0.3
———0.20.9
Reference items
17.517.015.012.99.6
7.4%8.3%9.9%8.9%6.9%
5.95.94.92.48.2
₹0.71₹0.71₹0.59₹0.29₹0.98
27.16×————
—0.45×0.48×0.29×1.13×
—5.13.83.22.5
————0.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MEDICO₹19.22

Medico Remedies Limited

· Pharma & Health
₹ CrorePeersMEDICAMEQHALEOSLABSAAREYDRUGSNECLIFEALBERTDAVDVALIANTLABNATCAPSUQZIMLABMcap ₹160 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.72.93.03.1—
+ Interest Income0.00.00.0-0.1—
+ Fair Value (Gains) / Losses0.00.00.0-0.0—
+ Other Non-cash Items0.30.6-0.60.0—
+ Other — Cash Effects are Investing / Financing0.50.10.10.0—
+ Other Reconciling Items0.00.00.00.2—
Changes in Working Capital
+ Inventories-1.63.4-10.4-3.3—
+ Trade Receivables — Current-5.7-13.6-7.00.0—
+ Trade Receivables — Non-current0.00.00.0-25.1—
+ Other Financial Assets — Current0.30.30.00.0—
+ Other Financial Assets — Non-current0.00.0-0.0-0.0—
+ Other Current Assets0.60.3-4.0-0.0—
+ Other Non-current Assets0.00.00.0-2.8—
+ Trade Payables — Current3.90.53.214.6—
+ Other Financial Liabilities — Current0.00.03.80.0—
+ Other Current Liabilities-0.2-0.07.11.8—
+ Other Non-current Liabilities0.00.00.04.7—
+ Provisions — Current-0.1-0.10.0-0.1—
Cash from Operating Activities
Profit Before Tax (per I/S)10.111.313.518.119.0
+ Total Adjustments (incl. Working Capital)0.6-5.6-4.7-7.1—
Cash from Operations (pre-tax)10.75.78.810.9—
+ Interest Received — Operating-0.1-0.1-0.10.0—
+ Income Taxes Paid2.53.23.85.1—
Cash from Operating Activities8.22.44.95.9—
Cash from Investing Activities
+ Disp of Fixed Assets0.00.00.00.1—
+ Acq of Investment Property0.10.10.10.4—
+ Loans & Advances Repaid0.00.00.00.0—
+ Interest Received — Investing0.10.10.10.1—
+ Other Inflows / (Outflows) — Investing-6.6-2.7-3.5-4.3—
Cash from Investing Activities-6.6-2.7-3.5-4.5—
Cash from Financing Activities
+ Repayment of Borrowings1.30.00.00.0—
+ Payment of Lease Liabilities0.50.50.50.6—
+ Interest Paid0.10.00.00.0—
Cash from Financing Activities-1.8-0.5-0.5-0.6—
Net Changes in Cash (pre-FX)-0.3-0.70.90.8—
Net Changes in Cash-0.3-0.70.90.8—
Closing Cash0.90.2———
Reference Items
EBITDA9.612.915.017.017.5
EBITDA Margin %6.858.919.948.257.37
Free Cash Flow (CFO − Capex)8.22.44.95.95.9
Free Cash Flow per Basic Share0.980.290.590.710.71
Price to Free Cash Flow————27.16
Cash Flow to Net Income1.130.290.480.45—
Cash Paid for Taxes2.53.23.85.1—
Cash Paid for Interest0.1————
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.